Tempus AI, Inc.
$56.06
▲
1.65%
2026-04-22 10:12:13
www.tempus.com
NMS: TEM
Explore Tempus AI, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$10.06 B
Current Price
$56.06
52W High / Low
$104.32 / $39.01
Stock P/E
—
Book Value
$2.76
Dividend Yield
—
ROCE
-13.29%
ROE
-89.48%
Face Value
—
EPS
$-1.41
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
3,800
Beta
—
Debt / Equity
270.11
Current Ratio
3.13
Quick Ratio
3
Forward P/E
-687.59
Price / Sales
6.06
Enterprise Value
$8.25 B
EV / EBITDA
-48.09
EV / Revenue
6.49
Rating
Buy
Target Price
$75.43
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
| 2. | HealthStream, Inc. | $21.34 | 34.36 | $630.28 M | 0.6% | 5.11% | 5.14% | $34.13 / $19.5 | $11.97 |
| 3. | DarioHealth Corp. | $7.46 | — | $54.46 M | — | -36.38% | -59.62% | $17.74 / $5.93 | $9.84 |
| 4. | SCWorx Corp. | $1.05 | — | $1.18 M | — | -27.93% | -76.35% | $13.05 / $0.76 | $0.52 |
| 5. | Omada Health, Inc. | $14.04 | — | $827.31 M | — | -5.21% | -8.68% | $28.4 / $10.28 | $3.93 |
| 6. | Teladoc Health, Inc. | $6.1 | — | $1.09 B | — | -6.66% | -13.93% | $9.77 / $4.4 | $7.77 |
| 7. | Definitive Healthcare Corp. | $1.05 | — | $147.1 M | — | -3.56% | -40.42% | $4.7 / $0.92 | $2.7 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 367.21 M | 334.21 M | 314.63 M | 255.74 M | 200.68 M | — |
| Operating Profit | -61.41 M | -61 M | -61.77 M | -68.69 M | -50.7 M | — |
| Net Profit | -54.17 M | -79.98 M | -42.84 M | -68.04 M | -13.01 M | — |
| EPS in Rs | -0.31 | -0.46 | -0.25 | -0.39 | -0.07 | -0.46 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.27 B | 693.4 M | 531.82 M | 320.67 M |
| Operating Profit | -252.87 M | -691.08 M | -196.08 M | -265.44 M |
| Net Profit | -245.03 M | -705.81 M | -214.12 M | -289.81 M |
| EPS in Rs | -1.41 | -4.05 | -1.23 | -1.66 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.27 B | 926.12 M | 564.05 M | 631.36 M |
| Total Liabilities | 1.78 B | 869.78 M | 1.95 B | 1.76 B |
| Equity | 491.33 M | 56.34 M | -1.38 B | -1.13 B |
| Current Assets | 1.17 B | 667.6 M | 350.33 M | 438.63 M |
| Current Liabilities | 372.39 M | 291.07 M | 232.63 M | 174.24 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -218.09 M | -189.04 M | -214.34 M | -168.2 M |
| Investing CF | -398.36 M | -130.39 M | -40.31 M | -57.94 M |
| Financing CF | 884.12 M | 494.33 M | 117.55 M | 251.39 M |
| Free CF | -245.35 M | -211.17 M | -248.95 M | -186.58 M |
| Capex | -27.27 M | -22.12 M | -34.61 M | -18.38 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 30.38% | 65.85% | — | — |
| Earnings Growth % | -229.64% | 26.12% | — | — |
| Profit Margin % | -101.79% | -40.26% | -90.38% | — |
| Operating Margin % | -99.67% | -36.87% | -82.78% | — |
| Gross Margin % | 54.96% | 53.81% | 40.6% | — |
| EBITDA Margin % | -88.03% | -25.07% | -73.86% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.